-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Current State and Local Tax Expense (Benefit) history and growth rate for Q1 2024.
- Hepion Pharmaceuticals, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$3M.
- Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2019 was -$11.4M.
- Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2017 was $1.6M, a 15.8% decline from 2016.
Current State and Local Tax Expense (Benefit), Quarterly (USD)